194 related articles for article (PubMed ID: 22484652)
21. Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age.
Girerd N; Nonin E; Pinot J; Morel E; Flys C; Scridon A; Chevalier P
Arch Cardiovasc Dis; 2011; 104(6-7):388-95. PubMed ID: 21798471
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead.
Morrison TB; Rea RF; Hodge DO; Crusan D; Koestler C; Asirvatham SJ; Bradley D; Shen WK; Munger TM; Hammill SC; Friedman PA
J Cardiovasc Electrophysiol; 2010 Jun; 21(6):671-7. PubMed ID: 20082653
[TBL] [Abstract][Full Text] [Related]
23. Pulse Generator Exchange Does Not Accelerate the Rate of Electrical Failure in a Recalled Small Caliber ICD Lead.
Lovelock JD; Premkumar A; Levy MR; Mengistu A; Hoskins MH; El-Chami MF; Lloyd MS; Leon AR; Langberg JJ; Delurgio DB
Pacing Clin Electrophysiol; 2015 Dec; 38(12):1434-8. PubMed ID: 26285670
[TBL] [Abstract][Full Text] [Related]
24. A cost-effectiveness analysis of a proactive management strategy for the Sprint Fidelis recall: a probabilistic decision analysis model.
Bashir J; Cowan S; Raymakers A; Yamashita M; Danter M; Krahn A; Lynd LD
Heart Rhythm; 2013 Dec; 10(12):1761-7. PubMed ID: 24076445
[TBL] [Abstract][Full Text] [Related]
25. Generator exchange is associated with an increased rate of Sprint Fidelis lead failure.
Lovelock JD; Patel A; Mengistu A; Hoskins M; El-Chami M; Lloyd MS; Leon A; DeLurgio D; Langberg JJ
Heart Rhythm; 2012 Oct; 9(10):1615-8. PubMed ID: 22683747
[TBL] [Abstract][Full Text] [Related]
26. Failure rates of single- versus dual-coil nonrecalled sprint quattro defibrillator leads.
Shariff N; Alluri K; Saba S
Am J Cardiol; 2015 Jan; 115(2):202-5. PubMed ID: 25465935
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of Sprint Fidelis and Riata lead extraction: Data from 2 high-volume centers.
El-Chami MF; Merchant FM; Levy M; Alam MB; Rattan R; Hoskins MH; Langberg JJ; Delurgio D; Lloyd MS; Leon AR; Saba S
Heart Rhythm; 2015 Jun; 12(6):1216-20. PubMed ID: 25998138
[TBL] [Abstract][Full Text] [Related]
28. Medtronic Sprint Fidelis lead recall: determining the initial 5-year management cost to Medicare.
Mehrotra AK; Knight BP; Smelley MP; Shah DP; Weisberg I; Baez-Escudero J; Beshai JF; Burke MC
Heart Rhythm; 2011 Aug; 8(8):1192-7. PubMed ID: 21377552
[TBL] [Abstract][Full Text] [Related]
29. Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient management.
Hauser RG; Maisel WH; Friedman PA; Kallinen LM; Mugglin AS; Kumar K; Hodge DO; Morrison TB; Hayes DL
Circulation; 2011 Feb; 123(4):358-63. PubMed ID: 21242478
[TBL] [Abstract][Full Text] [Related]
30. Passive-fixation lead failure rates and long-term patient mortality in subjects implanted with Sprint Fidelis electrodes.
Vollmann D; Woronowicz S; Kmiec L; Jung K; Zenker D; Seegers J; Sossalla S; Dorenkamp M; Sohns C; Lüthje L; Hasenfuss G; Zabel M
Europace; 2014 Feb; 16(2):258-64. PubMed ID: 23813451
[TBL] [Abstract][Full Text] [Related]
31. Fluoroscopic screening of asymptomatic patients implanted with the recalled Riata lead family.
Liu J; Rattan R; Adelstein E; Barrington W; Bazaz R; Brode S; Jain S; Mendenhall GS; Nemec J; Razak E; Shalaby A; Schwartzman D; Voigt A; Wang NC; Saba S
Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):809-14. PubMed ID: 22787015
[TBL] [Abstract][Full Text] [Related]
32. Transvenous extraction profile of Riata leads: procedural outcomes and technical complexity of mechanical removal.
Bongiorni MG; Di Cori A; Segreti L; Zucchelli G; Viani S; Paperini L; De Lucia R; Levorato D; Boem A; Soldati E
Heart Rhythm; 2015 Mar; 12(3):580-587. PubMed ID: 25499627
[TBL] [Abstract][Full Text] [Related]
33. Comparative outcomes of Riata and Fidelis lead management strategies: Results from the NCDR-ICD Registry.
Zeitler EP; Wang Y; Pokorney SD; Curtis J; Prutkin JM
Pacing Clin Electrophysiol; 2021 Nov; 44(11):1897-1906. PubMed ID: 34520564
[TBL] [Abstract][Full Text] [Related]
34. Management and long-term outcomes associated with recalled implantable cardioverter-defibrillator leads: A multicenter experience.
Mar PL; John A; Kumar S; Barry N; Chen G; Longserre S; Kabra R; Atkins D; Koerber S; Hussein A; Bhakta D; Lakkireddy D; Gopinathannair R
Heart Rhythm; 2020 Nov; 17(11):1909-1916. PubMed ID: 32512178
[TBL] [Abstract][Full Text] [Related]
35. Mechanical and electrical dysfunction of Riata implantable cardioverter-defibrillator leads.
Demirel F; Adiyaman A; Delnoy PP; Smit JJ; Ramdat Misier AR; Elvan A
Europace; 2014 Dec; 16(12):1787-94. PubMed ID: 24843049
[TBL] [Abstract][Full Text] [Related]
36. Trends in Fidelis lead survival: transition from an exponential to linear pattern of lead failure over time.
Cheung JW; Tobin-Hess A; Patel A; Slotwiner DJ; Goldner BG
Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):906-12. PubMed ID: 22923271
[TBL] [Abstract][Full Text] [Related]
37. Transvenous implantable cardioverter-defibrillator lead reliability: implications for postmarket surveillance.
Kramer DB; Hatfield LA; McGriff D; Ellis CR; Gura MT; Samuel M; Retel LK; Hauser RG
J Am Heart Assoc; 2015 May; 4(6):e001672. PubMed ID: 26025935
[TBL] [Abstract][Full Text] [Related]
38. Transvenous Implantable Cardioverter-Defibrillator (ICD) Lead Performance: A Meta-Analysis of Observational Studies.
Providência R; Kramer DB; Pimenta D; Babu GG; Hatfield LA; Ioannou A; Novak J; Hauser RG; Lambiase PD
J Am Heart Assoc; 2015 Oct; 4(11):. PubMed ID: 26518666
[TBL] [Abstract][Full Text] [Related]
39. Long-term single-center comparison of ICD lead survival: Evidence for premature Linox lead failure.
O'Connor M; Hooks D; Webber M; Shi B; Morrison S; Harding S; Larsen P
J Cardiovasc Electrophysiol; 2018 Jul; 29(7):1024-1031. PubMed ID: 29656578
[TBL] [Abstract][Full Text] [Related]
40. Lead electrical parameters may not predict integrity of the Sprint Fidelis ICD lead.
Maytin M; Epstein LM
Heart Rhythm; 2012 Sep; 9(9):1446-51. PubMed ID: 22537883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
